Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT
2007-000942-11Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel and aspirin in cardiac morbidity and arteriosclerosis obliterans (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Major adverse cardiovascular event rate. Started Apr 2008; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
cardiac morbidityarteriosclerosis obliterans
Beyond the preview
Go deeper on 2007-000942-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000942-11.